HEALTHCARE COSTS OF PATIENTS ON DIFFERENT RENAL REPLACEMENT MODALITIES - ANALYSIS OF DUTCH HEALTH INSURANCE CLAIMS DATA

被引:0
|
作者
van Oosten, Manon [2 ]
Mohnen, Sigrid [1 ]
Los, Jeanine [5 ]
Leegte, Martijn [4 ]
Jager, Kitty [6 ]
Hemmelder, Marc [4 ]
Logtenberg, Susan [3 ]
Stel, Vianda [6 ]
Hakkaart-van Roijen, Leona [5 ]
de Wit, G. Ardine [1 ,7 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[3] Diakonessen Hosp, Dept Internal Med, Utrecht, Netherlands
[4] Nefrovisie Fdn, Dutch Renal Registry Renine, Utrecht, Netherlands
[5] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Inst Med Technol Assessment, Rotterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Amsterdam Publ Hlth Res Inst,ERA EDTA Registry, Amsterdam, Netherlands
[7] Univ Med Ctr Utrecht, Juliusctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
FP673
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data
    Mohnen, Sigrid M.
    van Oosten, Manon J. M.
    Los, Jeanine
    Leegte, Martijn J. H.
    Jager, Kitty J.
    Hemmelder, Marc H.
    Logtenberg, Susan J. J.
    Stel, Vianda S.
    Hakkaart-van Roijen, Leona
    de Wit, G. Ardine
    [J]. PLOS ONE, 2019, 14 (08):
  • [2] End of life healthcare utilisation and costs of older patients receiving kidney replacement therapy-analysis of Dutch health insurance claims data
    Jongejan, Micha
    Van Oosten, Manon
    Leegte, Martijn
    van Buren, Marjolijn
    Abrahams, Alferso
    Bos, Willem Jan W.
    Voorend, Carlijn
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1369 - I1370
  • [3] COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH AND WITHOUT BULLOUS PEMPHIGOID: A RETROSPECTIVE ANALYSIS OF US HEALTH INSURANCE CLAIMS DATA
    Xu, X.
    Datto, C.
    Kwiatek, J.
    Meyers, J.
    Candrilli, S.
    Mines, D.
    Stirnadel-Farrant, H.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [4] Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data
    Ki, Moran
    Choi, Hwa Young
    Kim, Kyung-Ah
    Jang, Eun Sun
    Jeong, Sook-Hyang
    [J]. GUT AND LIVER, 2017, 11 (06) : 835 - 842
  • [5] AGE-RELATED DIFFERENCE IN HEALTHCARE USE AND COSTS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND MATCHED CONTROLS: ANALYSIS OF DUTCH HEALTHCARE CLAIMS DATA
    van Oosten, Manon
    Logtenberg, Susan
    Leegte, Martijn
    Bilo, Henk
    Mohnen, Sigrid
    Hakkaart-Van Roijen, Leona
    Hemmelder, Marc
    De Wit, Ardine
    Jager, Kitty
    Stel, Vianda
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 184 - 184
  • [6] Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
    Dolin, Paul
    Kielar, Danuta
    Shavit, Anat
    Keogh, Karina
    Rowell, Jennifer
    Edmonds, Chris
    Meyers, Juliana
    Esterberg, Elizabeth
    Nham, Tram
    Chen, Stephanie
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB206 - AB206
  • [7] Employment status and indirect costs in patients with renal failure: differences between different modalities of renal replacement therapy
    Julian-Mauro, Juan C.
    Cuervo, Jesus
    Rebollo, Pablo
    Callejo, Daniel
    [J]. NEFROLOGIA, 2013, 33 (03): : 333 - 341
  • [8] INCREASE IN DIRECT HEALTHCARE COSTS IN JUVENILE IDIOPATHIC ARTHRITIS OVER THE PAST 10 YEARS - RESULTS OF A HEALTH INSURANCE CLAIMS DATA ANALYSIS
    Redeker, I.
    Hoffmann, F.
    Albrecht, K.
    Klotsche, J.
    Zink, A.
    Minden, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 100 - 100
  • [9] A RETROSPECTIVE CLAIMS ANALYSIS OF US HEALTH PLAN COMMERCIAL INSURANCE DATA ASSESSING HEALTHCARE COSTS AND RELAPSE RATES IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH GENERIC GLATIRAMER ACETATE
    Greenberg, B.
    Grabner, M.
    Zhang, X.
    Balu, S.
    Hall, S.
    Kantor, D.
    [J]. VALUE IN HEALTH, 2019, 22 : S272 - S272
  • [10] Using claims data to understand the costs of different health states for patients with cardiometabolic risk
    Mangiapane, S.
    Gothe, H.
    Schiffhorst, G.
    Aidelsburger, P.
    Fuchs, S. M.
    Wasem, J.
    Glaeske, G.
    Haeussler, B.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A325 - A325